GlassScriptPhysician profile
Scott N Sheftel
NPI 1134128564
$11,198.49
in general payments reported to CMS, 2019-2025
33 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,428 · 2020: $625 · 2021: $790 · 2022: $3,182 · 2023: $1,402 · 2024: $1,559 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,150 · Education: $23.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,149.79 |
| Education | $23.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragenics Corporation | $2,439.20 | 2022 | |
| Genzyme Corporation | $1,959.50 | 2019-2025 | |
| Abbvie INC. | $1,602.69 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $1,208.51 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Leo Pharma INC. | $590.13 | 2019-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $571.45 | 2019-2025 | Libtayo, Dupixent |
| Pfizer INC. | $552.15 | 2019-2025 | |
| Lilly USA, LLC | $395.13 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $394.94 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $232.85 | 2020-2025 | Blu-U, Odomzo |
| Hill Dermaceuticals, INC. | $168.29 | 2024-2025 | Tolak |
| Sanofi-Aventis U.S. LLC | $140.56 | 2019-2021 | |
| Ucb, INC. | $136.66 | 2019-2025 | Bimzelx |
| Kyowa Kirin, INC. | $102.02 | 2022 | |
| Amgen INC. | $91.59 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $69.52 | 2019-2023 | |
| Allergan, INC. | $68.55 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.84 | 2019-2024 | Duobrii, Siliq |
| Abbott Laboratories | $48.12 | 2023 | Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $48.11 | 2023-2024 | Sotyktu |
| Biofrontera INC. | $44.00 | 2019-2021 | |
| Genentech USA, INC. | $40.63 | 2019-2023 | Xolair |
| Arcutis Biotherapeutics, INC. | $35.59 | 2023 | |
| Dermavant Sciences, INC. | $30.07 | 2023-2024 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.47 | 2025 | Spevigo |
| Merck Sharp & Dohme LLC | $24.50 | 2019 | |
| Dusa Pharmaceuticals, INC. | $23.50 | 2019 | |
| Prugen, INC. Pharmaceuticals | $19.94 | 2019 | |
| Fidia Pharma USA INC. | $17.43 | 2025 | |
| Biowound Solutions, INC. | $16.90 | 2025 | Bio-Connekt |
| Strata Skin Sciences, INC. | $16.30 | 2025 | Xtrac |
| Smith+Nephew, INC. | $15.10 | 2025 | Collagenase Santyl |
| Sensus Healthcare, INC. | $10.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sheftel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.